{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:35:06Z","timestamp":1767202506987,"version":"3.48.0"},"reference-count":205,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wanek Family Foundation to Cure Type 1 Diabetes Innovative Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cell surface immune checkpoint receptors are objects for therapeutic intervention to stimulate immune cell attack of cancers. Interference between the checking ectodomain (ECD) and the natural ligand lowers constitutive restraints exerted on immune cells. This approach assumes that immune cells can do more, that a checkpoint blocker will make immune cells more effective at killing cancer cells, and that checkpoint molecules might have limited physiological roles. These assumptions may be warranted, as in the case of checkpoint-blockers towards the programmed death-ligand 1 (PD-L1) ECD, where clinical outcomes are consistently good. However, this does not appear to be the case for the universally expressed CD47 ECD. Much effort has been directed at engineering molecules that bind to the CD47 ECD to increase T cell and macrophage killing of cancers. But a wealth of clinical data do not indicate strong signals, improved killing, or meaningful survival advantages. This suggests that the CD47 ECD is a subpar target for cancer therapy. Consideration of reasons accounting for the modest benefits realized by molecules that bind to the CD47 ECD in cancer, also known as Plan A, is provided. This is followed by thoughts on what might be done, known as plan B, to identify advantages within the CD47 ECD for modulating tolerance in autoimmune diseases.<\/jats:p>","DOI":"10.3390\/cells15010071","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:24:58Z","timestamp":1767201898000},"page":"71","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["If Plan A Does Not Work: The CD47 Ectodomain as a Target for Immune Tolerance"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7127-6675","authenticated-orcid":false,"given":"Enrique","family":"Montero","sequence":"first","affiliation":[{"name":"Department of Diabetes Immunology, 1500 Duarte Road, Duarte, CA 91010, USA"},{"name":"Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-1688","authenticated-orcid":false,"given":"Jeffrey S.","family":"Isenberg","sequence":"additional","affiliation":[{"name":"Department of Diabetes Complications & Metabolism, 1500 Duarte Road, Duarte, CA 91010, USA"},{"name":"Arthur Riggs Diabetes & Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI22685","article-title":"Immune recognition of self in immunity against cancer","volume":"114","author":"Houghton","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.103085","article-title":"A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma","volume":"99","author":"Korde","year":"2014","journal-title":"Haematologica"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2012-06-437558","article-title":"A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission","volume":"120","author":"Vey","year":"2012","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s13046-025-03571-9","article-title":"Enhancing anti-tumour immunity through modulating dendritic cell activation by combination therapy with a novel TLR2 agonist and PD-L1 Blockade","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Alsaab, H.O., Sau, S., Alzhrani, R., Tatiparti, K., Bhise, K., Kashaw, S.K., and Iyer, A.K. (2017). PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00561"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e000247","DOI":"10.1136\/esmoopen-2017-000247","article-title":"Cardiotoxicity of immune checkpoint inhibitors","volume":"2","author":"Varricchi","year":"2017","journal-title":"ESMO Open"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1634\/theoncologist.2015-0509","article-title":"Immune Checkpoint Inhibitors: Review and Management of Endocrine Adverse Events","volume":"21","year":"2016","journal-title":"Oncologist"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhou, X., Ni, Y., Liang, X., Lin, Y., An, B., He, X., and Zhao, X. (2022). Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.915094"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ursino, C., Mouric, C., Gros, L., Bonnefoy, N., and Faget, J. (2023). Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1170321"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.32624","article-title":"Real-world use and survival outcomes of immune checkpoint inhibitors in older adults with non-small cell lung cancer","volume":"126","author":"Youn","year":"2020","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41571-019-0260-y","article-title":"A reality check of the accelerated approval of immune-checkpoint inhibitors","volume":"16","author":"Gill","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"BSR20202130","DOI":"10.1042\/BSR20202130","article-title":"Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells","volume":"40","author":"Cong","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e88628","DOI":"10.1172\/jci.insight.88628","article-title":"Lymphocyte activation gene 3 and coronary artery disease","volume":"1","author":"Golden","year":"2016","journal-title":"JCI Insight"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1073\/pnas.1120606109","article-title":"Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering","volume":"109","author":"Stengel","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/01.tp.0000256293.90270.e8","article-title":"Involvement of the programmed death-1\/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses","volume":"83","author":"Kitazawa","year":"2007","journal-title":"Transplantation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/eji.200737583","article-title":"Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance","volume":"37","author":"Wang","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/bj3040525","article-title":"Isolation and characterization of CD47 glycoprotein: A multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3","volume":"304","author":"Mawby","year":"1994","journal-title":"Biochem. J."},{"key":"ref_23","first-page":"83","article-title":"CD47 (Cluster of Differentiation 47)","volume":"25","author":"Kaur","year":"2021","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1535-7163.MCT-19-1079","article-title":"Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding","volume":"19","author":"Puro","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood.2019002194","article-title":"A human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells","volume":"135","author":"Jinnouchi","year":"2020","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kaur, S., Kuznetsova, S.A., Sipes, J.M., Singh, S.P., Villasmil, R., and Roberts, D.D. (2025). T Cell Activation Induces Synthesis of CD47 Proteoglycan Isoforms and Their Release in Extracellular Vesicles. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178377"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2353\/ajpath.2008.080237","article-title":"Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury","volume":"173","author":"Isenberg","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.matbio.2014.05.003","article-title":"Thrombospondin-1 and CD47 signaling regulate healing of thermal injury in mice","volume":"37","author":"Shih","year":"2014","journal-title":"Matrix Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"L1150","DOI":"10.1152\/ajplung.00302.2018","article-title":"Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice","volume":"316","author":"Novelli","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"29637","DOI":"10.1074\/jbc.M500922200","article-title":"CD47 augments Fas\/CD95-mediated apoptosis","volume":"280","author":"Manna","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1074\/jbc.M804860200","article-title":"Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses","volume":"284","author":"Isenberg","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.matbio.2010.12.004","article-title":"Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47","volume":"30","author":"Frazier","year":"2011","journal-title":"Matrix Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"24858","DOI":"10.1074\/jbc.M115.665752","article-title":"CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation","volume":"290","author":"Miller","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1038\/s41467-021-25475-w","article-title":"Structure of the human marker of self 5-transmembrane receptor CD47","volume":"12","author":"Fenalti","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molcel.2008.05.026","article-title":"Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47","volume":"31","author":"Hatherley","year":"2008","journal-title":"Mol. Cell."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41591-019-0356-z","article-title":"Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPalpha axis and a target for cancer immunotherapy","volume":"25","author":"Logtenberg","year":"2019","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1074\/jbc.M110.179663","article-title":"Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1","volume":"286","author":"Kaur","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, T., Wang, F., Xu, L., and Yang, Y.G. (2024). Structural-functional diversity of CD47 proteoforms. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1329562"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/cvr\/cvq218","article-title":"Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation","volume":"88","author":"Bauer","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100129","DOI":"10.1016\/j.mcpro.2021.100129","article-title":"Decoding Post-Translational Modification Crosstalk With Proteomics","volume":"20","author":"Leutert","year":"2021","journal-title":"Mol. Cell Proteomics"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Brandhorst, T.T., Roy, R., Wuthrich, M., Nanjappa, S., Filutowicz, H., Galles, K., Tonelli, M., McCaslin, D.R., Satyshur, K., and Klein, B. (2013). Structure and function of a fungal adhesin that binds heparin and mimics thrombospondin-1 by blocking T cell activation and effector function. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003464"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/bit.20684","article-title":"Post-translational regulation of expression and conformation of an immunoglobulin domain in yeast surface display","volume":"93","author":"Parthasarathy","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/me.2007-0552","article-title":"Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I","volume":"22","author":"Maile","year":"2008","journal-title":"Mol. Endocrinol."},{"key":"ref_45","first-page":"2130","article-title":"CD47 is a ligand for rat macrophage membrane signal regulatory protein SIRP (OX41) and human SIRPalpha 1","volume":"30","author":"Kee","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"38923","DOI":"10.1074\/jbc.M110.172304","article-title":"Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47","volume":"285","author":"Kaur","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1083\/jcb.135.2.533","article-title":"Thrombospondin modulates alpha v beta 3 function through integrin-associated protein","volume":"135","author":"Gao","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M312782200","article-title":"Cholesterol-independent interactions with CD47 enhance alphavbeta3 avidity","volume":"279","author":"McDonald","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0","article-title":"Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts","volume":"31","author":"Pfeiffer","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood-2002-04-1285","article-title":"Evidence that the red cell skeleton protein 4.2 interacts with the Rh membrane complex member CD47","volume":"101","author":"Delaunay","year":"2003","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41590-023-01671-2","article-title":"CD47 masks pro-phagocytic ligands in cis on tumor cells to suppress antitumor immunity","volume":"24","author":"Tang","year":"2023","journal-title":"Nat. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103024","DOI":"10.1016\/j.jbc.2023.103024","article-title":"The CIS association of CD47 with integrin Mac-1 regulates macrophage responses by stabilizing the extended integrin conformation","volume":"299","author":"Podolnikova","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1074\/jbc.274.13.8554","article-title":"The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi","volume":"274","author":"Frazier","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"eadv5085","DOI":"10.1126\/sciimmunol.adv5085","article-title":"Anticancer immune responses are hindered by cis interaction of inhibitory checkpoint SIRPalpha","volume":"10","author":"Tang","year":"2025","journal-title":"Sci. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yu, J., Li, S., Chen, D., Liu, D., Guo, H., Yang, C., Zhang, W., Zhang, L., Zhao, G., and Tu, X. (2022). Crystal Structure of Human CD47 in Complex with Engineered SIRPalpha.D1(N80A). Molecules, 27.","DOI":"10.3390\/molecules27175574"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00262-023-03465-9","article-title":"The TSP1-CD47-SIRP\u03b1 interactome: An immune triangle for the checkpoint era","volume":"72","author":"Montero","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"20180217","DOI":"10.1098\/rstb.2018.0217","article-title":"The macrophage checkpoint CD47: SIRPalpha for recognition of \u2018self\u2019 cells: From clinical trials of blocking antibodies to mechanobiological fundamentals","volume":"374","author":"Andrechak","year":"2019","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"31113","DOI":"10.1074\/jbc.M115.682914","article-title":"Cleavage of Signal Regulatory Protein alpha (SIRPalpha) Enhances Inflammatory Signaling","volume":"290","author":"Londino","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1111\/febs.70192","article-title":"Enhancing macrophage phagocytosis of cancers by disrupting the SIRPalpha\/CD47 signaling axis and targeting MUC1 antigen","volume":"292","author":"Muneekaew","year":"2025","journal-title":"FEBS J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1074\/jbc.M705203200","article-title":"Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain","volume":"283","author":"Tan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nsmb997","article-title":"Structure of the calcium-rich signature domain of human thrombospondin-2","volume":"12","author":"Carlson","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.emboj.7600166","article-title":"Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats","volume":"23","author":"Kvansakul","year":"2004","journal-title":"EMBO J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1139\/o01-210","article-title":"Gene for integrin-associated protein (IAP, CD47): Physical mapping, genomic structure, and expression studies in skeletal muscle","volume":"80","author":"Schickel","year":"2002","journal-title":"Biochem. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature14321","article-title":"Alternative 3\u2032 UTRs act as scaffolds to regulate membrane protein localization","volume":"522","author":"Berkovits","year":"2015","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/intimm\/11.5.707","article-title":"Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein\/CD47 and CD28","volume":"11","author":"Reinhold","year":"1999","journal-title":"Int. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2001-12-0217","article-title":"Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: Link between phosphatidylserine exposure and cytoskeleton organization","volume":"100","author":"Mateo","year":"2002","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1083\/jcb.134.5.1313","article-title":"Integrin-associated protein immunoglobulin domain is necessary for efficient vitronectin bead binding","volume":"134","author":"Lindberg","year":"1996","journal-title":"J. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"mjae041","DOI":"10.1093\/jmcb\/mjae041","article-title":"Super-resolution microscopy unveils the nanoscale organization and self-limiting clustering of CD47 in human erythrocytes","volume":"16","author":"Yang","year":"2025","journal-title":"J. Mol. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1034\/j.1399-0039.2000.560308.x","article-title":"CDw149 antibodies recognize a clustered subset of CD47 molecules associated with cytoplasmic signaling molecules","volume":"56","author":"Drbal","year":"2000","journal-title":"Tissue Antigens"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bcmd.2006.01.012","article-title":"Membrane mobility and clustering of Integrin Associated Protein (IAP, CD47)\u2014Major differences between mouse and man and implications for signaling","volume":"36","author":"Subramanian","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"21626","DOI":"10.1021\/acsnano.3c06709","article-title":"Quantitatively Lighting up the Spatial Organization of CD47\/SIRPalpha Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy","volume":"17","author":"Wei","year":"2023","journal-title":"ACS Nano"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbrc.2003.08.031","article-title":"Regulation of multiple functions of SHPS-1, a transmembrane glycoprotein, by its cytoplasmic region","volume":"309","author":"Sato","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"37953","DOI":"10.1074\/jbc.M110.180018","article-title":"The role of cis dimerization of signal regulatory protein alpha (SIRPalpha) in binding to CD47","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.tibs.2014.08.001","article-title":"Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases","volume":"39","author":"Endres","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"118496","DOI":"10.1016\/j.bbamcr.2019.06.010","article-title":"Discoidin domain receptors: Micro insights into macro assemblies","volume":"1866","author":"Agarwal","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molimm.2017.12.005","article-title":"The regulatory network behind MHC class I expression","volume":"113","author":"Jongsma","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.16.1.323","article-title":"Mechanisms of MHC class I\u2014Restricted antigen processing","volume":"16","author":"Pamer","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"jcs216770","DOI":"10.1242\/jcs.216770","article-title":"Membrane fluctuations and acidosis regulate cooperative binding of \u2018marker of self\u2019 protein CD47 with the macrophage checkpoint receptor SIRPalpha","volume":"132","author":"Steinkuhler","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically Modified Porcine-to-Human Cardiac Xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41591-023-02471-9","article-title":"Pig-to-human heart xenotransplantation in two recently deceased human recipients","volume":"29","author":"Moazami","year":"2023","journal-title":"Nat. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4285\/ctr.24.0065","article-title":"Current status of xenotransplantation from an immunobiological standpoint","volume":"39","author":"Ko","year":"2025","journal-title":"Clin. Transplant. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41586-023-06594-4","article-title":"Design and testing of a humanized porcine donor for xenotransplantation","volume":"622","author":"Anand","year":"2023","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e12549","DOI":"10.1111\/xen.12549","article-title":"Transgenic expression of human CD47 reduces phagocytosis of porcine endothelial cells and podocytes by baboon and human macrophages","volume":"27","author":"Nomura","year":"2020","journal-title":"Xenotransplantation"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Cooper, D.K.C., and Cozzi, E. (2024). Clinical Pig Heart Xenotransplantation\u2014Where Do We Go From Here?. Transpl. Int., 37.","DOI":"10.3389\/ti.2024.12592"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0000000000000252","article-title":"CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model","volume":"98","author":"Lin","year":"2014","journal-title":"Transplantation"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/ajt.14523","article-title":"CD47 blockade reduces ischemia\/reperfusion injury in donation after cardiac death rat kidney transplantation","volume":"18","author":"Wang","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.kint.2016.03.034","article-title":"CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion","volume":"90","author":"Rogers","year":"2016","journal-title":"Kidney Int."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/SLA.0b013e31816c4006","article-title":"Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: Implications for human disease","volume":"247","author":"Isenberg","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/SLA.0b013e31815685dc","article-title":"Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts","volume":"247","author":"Isenberg","year":"2008","journal-title":"Ann. Surg."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/01.RES.0000259579.35787.4e","article-title":"Increasing survival of ischemic tissue by targeting CD47","volume":"100","author":"Isenberg","year":"2007","journal-title":"Circ. Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Jajosky, R.P., Covington, M.L., Liu, J., Chai, L., Zerra, P.E., Chonat, S., Stowell, S.R., and Arthur, C.M. (2025). CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1548548"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1399-0039.1985.tb00929.x","article-title":"HLA antigens on peripheral red blood cells: Analysis by flow cytofluorometry using monoclonal antibodies","volume":"26","author":"Rouger","year":"1985","journal-title":"Tissue Antigens"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1537-2995.2007.01348.x","article-title":"Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation","volume":"47","author":"Khandelwal","year":"2007","journal-title":"Transfusion"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood-2007-06-098392","article-title":"Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide\/cGMP signaling","volume":"111","author":"Isenberg","year":"2008","journal-title":"Blood"},{"key":"ref_95","first-page":"E347","article-title":"Thrombospondin-1, CD47, and SIRPalpha Display Cell-Specific Molecular Signatures in Human Islets and Pancreata","volume":"324","author":"Erdem","year":"2023","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2249.2010.04235.x","article-title":"CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction","volume":"162","author":"Nair","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"103228","DOI":"10.1016\/j.jaut.2024.103228","article-title":"The CD318\/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation","volume":"146","author":"Do","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hu, Z., Zhang, Q., He, Z., Jia, X., Zhang, W., and Cao, X. (2024). MHC1\/LILRB1 axis as an innate immune checkpoint for cancer therapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1421092"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/intimm\/dxn135","article-title":"Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes","volume":"21","author":"Beauchamp","year":"2009","journal-title":"Int. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e2304943120","DOI":"10.1073\/pnas.2304943120","article-title":"CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis","volume":"120","author":"Komori","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2111909","DOI":"10.1080\/2162402X.2022.2111909","article-title":"Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice","volume":"11","author":"Nath","year":"2022","journal-title":"Oncoimmunology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s00262-019-02397-7","article-title":"Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation","volume":"68","author":"Schwartz","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood.V97.9.2741","article-title":"Signal-regulatory protein alpha (SIRPalpha) but not SIRPbeta is involved in T-cell activation, binds to CD47 with high affinity, and is expressed on immature CD34+CD38\u2212 hematopoietic cells","volume":"97","author":"Seiffert","year":"2001","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \u201cSelf\u201d peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chembiol.2020.06.008","article-title":"Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPalpha Interaction as a Potential Cancer Immunotherapy","volume":"27","author":"Hazama","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Embgenbroich, M., and Burgdorf, S. (2018). Current Concepts of Antigen Cross-Presentation. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01643"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/odi.13922","article-title":"Inhibitory effects of circulating natural autoantibodies to CD47-derived peptides on OSCC cells","volume":"29","author":"Liu","year":"2023","journal-title":"Oral. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Park, J.K., Lee, Y.J., Park, J.S., Lee, E.B., and Song, Y.W. (2021). CD47 Potentiates Inflammatory Response in Systemic Lupus Erythematosus. Cells, 10.","DOI":"10.3390\/cells10051151"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0167-5699(00)01633-9","article-title":"Autoimmunity can benefit self-maintenance","volume":"21","author":"Schwartz","year":"2000","journal-title":"Immunol. Today"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1568-9972(01)00015-5","article-title":"Autoimmunization to epidermal growth factor, a component of the immunological homunculus","volume":"1","author":"Gonzalez","year":"2002","journal-title":"Autoimmun Rev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1038\/s41467-019-12968-y","article-title":"Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo","volume":"10","author":"Reed","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"23915","DOI":"10.1074\/jbc.M301869200","article-title":"CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis","volume":"278","author":"Lamy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S1097-2765(00)80212-9","article-title":"Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane","volume":"4","author":"Wu","year":"1999","journal-title":"Mol. Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"26655","DOI":"10.1074\/jbc.M302194200","article-title":"Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain","volume":"278","author":"Fujimoto","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12964-020-00651-5","article-title":"Thrombospondin-1\/CD47 signaling modulates transmembrane cation conductance, survival, and deformability of human red blood cells","volume":"18","author":"Bissinger","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e000670","DOI":"10.1161\/JAHA.113.000670","article-title":"Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3","volume":"3","author":"Shoushtari","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1681\/ASN.2013040433","article-title":"Thrombospondin-1 activation of signal-regulatory protein-alpha stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury","volume":"25","author":"Yao","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/imm.12290","article-title":"Signal-regulatory protein \u03b1 from the NOD mouse binds human CD47 with an exceptionally high affinity\u2014Implications for engraftment of human cells","volume":"143","author":"Kwong","year":"2014","journal-title":"Immunology"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Miller, T.W., Amason, J.D., Garcin, E.D., Lamy, L., Dranchak, P.K., Macarthur, R., Braisted, J., Rubin, J.S., Burgess, T.L., and Farrell, C.L. (2019). Quantitative high-throughput screening assays for the discovery and development of SIRP\u03b1-CD47 interaction inhibitors. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218897"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Liu, J., Wang, L., Zhao, F., Tseng, S., Narayanan, C., Shura, L., Willingham, S., Howard, M., Prohaska, S., and Volkmer, J. (2015). Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137345"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/MCB.16.11.5955","article-title":"Involvement of the protein tyrosine phosphatase SHP-1 in Ras-mediated activation of the mitogen-activated protein kinase pathway","volume":"16","author":"Krautwald","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s000180050369","article-title":"The stress-activated protein kinase pathways","volume":"55","author":"Tibbles","year":"1999","journal-title":"Cell Mol. Life Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbadis.2013.11.003","article-title":"Modulation in the expression of SHP-1, SHP-2 and PTP1B due to the inhibition of MAPKs, cAMP and neutrophils early on in the development of cerulein-induced acute pancreatitis in rats","volume":"1842","author":"Sarmiento","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"35710","DOI":"10.1074\/jbc.M305078200","article-title":"The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of Fc gamma RIIa to modulate signaling events in myeloid cells","volume":"278","author":"Ganesan","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.it.2013.02.004","article-title":"Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells","volume":"34","author":"Kortum","year":"2013","journal-title":"Trends Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1034\/j.1600-065X.2003.00019.x","article-title":"JNK and p38 MAP kinases in CD4+ and CD8+ T cells","volume":"192","author":"Rincon","year":"2003","journal-title":"Immunol. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.4049\/jimmunol.175.7.4450","article-title":"Binding of IgG-opsonized particles to Fc gamma R is an active stage of phagocytosis that involves receptor clustering and phosphorylation","volume":"175","author":"Sobota","year":"2005","journal-title":"J. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1093\/cvr\/cvab369","article-title":"Loss of myeloid cell-specific SIRPalpha, but not CD47, attenuates inflammation and suppresses atherosclerosis","volume":"118","author":"Singla","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"42859","DOI":"10.1074\/jbc.M206849200","article-title":"Regulation of integrin function by CD47 ligands. Differential effects on alpha vbeta 3 and alpha 4beta1 integrin-mediated adhesion","volume":"277","author":"Barazi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_133","first-page":"291","article-title":"THBS1 (thrombospondin-1)","volume":"24","author":"Isenberg","year":"2020","journal-title":"Atlas Genet. Cytogenet. Oncol. Haematol."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Kaur, S., Bronson, S.M., Pal-Nath, D., Miller, T.W., Soto-Pantoja, D.R., and Roberts, D.D. (2021). Functions of Thrombospondin-1 in the Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094570"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2009.06.121","article-title":"CD47 promotes both phosphatidylserine-independent and phosphatidylserine-dependent phagocytosis of apoptotic murine thymocytes by non-activated macrophages","volume":"387","author":"Nilsson","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.1401719","article-title":"Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPalpha Facilitate Apoptotic Cell Clearance by Macrophages","volume":"195","author":"Lv","year":"2015","journal-title":"J. Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3727\/096368911X566253","article-title":"Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPalpha capable of binding to human CD47","volume":"20","author":"Wang","year":"2011","journal-title":"Cell Transplant."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood-2006-04-019794","article-title":"Attenuation of phagocytosis of xenogeneic cells by manipulating CD47","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1073\/pnas.0609661104","article-title":"Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages","volume":"104","author":"Ide","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41577-024-01022-8","article-title":"Engineering immune-evasive allogeneic cellular immunotherapies","volume":"24","author":"Martin","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","article-title":"Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate","volume":"31","author":"Hu","year":"2024","journal-title":"Cell Stem Cell"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e12459","DOI":"10.1111\/xen.12459","article-title":"Elimination of donor CD47 protects against vascularized allograft rejection in mice","volume":"26","author":"Chen","year":"2019","journal-title":"Xenotransplantation"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/TP.0000000000001186","article-title":"Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody","volume":"100","author":"Xiao","year":"2016","journal-title":"Transplantation"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/lt.24059","article-title":"CD47 blockade reduces ischemia\/reperfusion injury and improves survival in a rat liver transplantation model","volume":"21","author":"Xiao","year":"2015","journal-title":"Liver Transpl."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/ajt.14567","article-title":"Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death","volume":"18","author":"Xu","year":"2018","journal-title":"Am. J. Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"5718","DOI":"10.4049\/jimmunol.171.11.5718","article-title":"Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1","volume":"171","author":"Tada","year":"2003","journal-title":"J. Immunol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","article-title":"Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte","volume":"123","author":"Gardai","year":"2005","journal-title":"Cell"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.immuni.2022.10.018","article-title":"Neuronal signal-regulatory protein alpha drives microglial phagocytosis by limiting microglial interaction with CD47 in the retina","volume":"55","author":"Jiang","year":"2022","journal-title":"Immunity"},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhang, X., Dong, L., Zhu, N., Zhou, D., Li, S., Lv, J., Wumaier, G., Wang, J., and Zeng, Y. (2025). The interplay between M2-like macrophages and Th17.1 cells promotes the progression of early-stage sarcoidosis. Cell Commun. Signal.","DOI":"10.1186\/s12964-025-02566-5"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1091\/mbc.7.11.1789","article-title":"Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells","volume":"7","author":"Coopman","year":"1996","journal-title":"Mol. Biol. Cell"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.4049\/jimmunol.161.11.6250","article-title":"CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3)","volume":"161","author":"Fadok","year":"1998","journal-title":"J. Immunol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Torres-Gomez, A., Sanchez-Trincado, J.L., Toribio, V., Torres-Ruiz, R., Rodriguez-Perales, S., Yanez-Mo, M., Reche, P.A., Cabanas, C., and Lafuente, E.M. (2020). RIAM-VASP Module Relays Integrin Complement Receptors in Outside-In Signaling Driving Particle Engulfment. Cells, 9.","DOI":"10.3390\/cells9051166"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"24219","DOI":"10.1074\/jbc.M701565200","article-title":"Dual regulation of SIRPalpha phosphorylation by integrins and CD47","volume":"282","author":"Johansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1556\/1886.2025.00065","article-title":"CD47 monoclonal antibodies differ in their capacity to induce immune response","volume":"15","author":"Cham","year":"2025","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Zhang, H., He, F., Cao, L., Ni, H., Li, N., Liu, Y., Wu, M., Liu, Y., Wu, B., and Li, L. (2025). A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPalpha-Independent Mechanism. Mol. Cancer Ther.","DOI":"10.1158\/1535-7163.MCT-25-0425"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Krishnamoorthy, M., Seelige, R., Brown, C.R., Chau, N., Nielsen Viller, N., Johnson, L.D.S., Linderoth, E., Wang, J.C.Y., Dillon, C.P., and Abayasiriwardana, K. (2025). Maplirpacept: A CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1518787"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/imm.12009","article-title":"Role of recombination activating genes in the generation of antigen receptor diversity and beyond","volume":"137","author":"Nishana","year":"2012","journal-title":"Immunology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"jcs237800","DOI":"10.1242\/jcs.237800","article-title":"Macrophages show higher levels of engulfment after disruption of cis interactions between CD47 and the checkpoint receptor SIRPalpha","volume":"133","author":"Hayes","year":"2020","journal-title":"J. Cell Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvv243","article-title":"HIF-2alpha-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction","volume":"109","author":"Rogers","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"ref_160","first-page":"296069","article-title":"Thrombospondin-1: Multiple paths to inflammation","volume":"2011","author":"Pidcock","year":"2011","journal-title":"Mediators Inflamm."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1158\/0008-5472.CAN-08-0643","article-title":"Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells","volume":"68","author":"Galli","year":"2008","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1582-4934.2009.00799.x","article-title":"Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance","volume":"14","author":"Kirsch","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"eaaj1784","DOI":"10.1126\/scisignal.aaj1784","article-title":"The matricellular protein TSP1 promotes human and mouse endothelial cell senescence through CD47 and Nox1","volume":"10","author":"Meijles","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2017-09-809004","article-title":"NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages","volume":"131","author":"Bagaitkar","year":"2018","journal-title":"Blood"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41419-021-04486-x","article-title":"Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress","volume":"13","author":"Tseng","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Shamim, A., Abdul Aziz, M., Saeed, F., Kumari, R., Mary Joseph, A., Ponnachan, P., Kishore, U., and Masmoudi, K. (2024). Revisiting surfactant protein D: An immune surveillance molecule bridging innate and adaptive immunity. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1491175"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.200711-1661OC","article-title":"Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha","volume":"178","author":"Janssen","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"19386","DOI":"10.1074\/jbc.M111.324533","article-title":"Surfactant protein D (Sp-D) binds to membrane-proximal domain (D3) of signal regulatory protein alpha (SIRPalpha), a site distant from binding domain of CD47, while also binding to analogous region on signal regulatory protein beta (SIRPbeta)","volume":"287","author":"Fournier","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s11886-023-01978-4","article-title":"Genetic Engineering of Donor Pig for the First Human Cardiac Xenotransplantation: Combatting Rejection, Coagulopathy, Inflammation, and Excessive Growth","volume":"25","author":"Singireddy","year":"2023","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/TP.0000000000003688","article-title":"Improving Liver Graft Function Using CD47 Blockade in the Setting of Normothermic Machine Perfusion","volume":"106","author":"Xu","year":"2022","journal-title":"Transplantation"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"83040","DOI":"10.18632\/oncotarget.13349","article-title":"A fully human anti-CD47 blocking antibody with therapeutic potential for cancer","volume":"7","author":"Zeng","year":"2016","journal-title":"Oncotarget"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.2147\/OTT.S249822","article-title":"Potential New Cancer Immunotherapy: Anti-CD47-SIRPalpha Antibodies","volume":"13","author":"Lu","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.92.9.3978","article-title":"Transendothelial migration of neutrophils involves integrin-associated protein (CD47)","volume":"92","author":"Cooper","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4049\/jimmunol.158.2.677","article-title":"Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells","volume":"158","author":"Ticchioni","year":"1997","journal-title":"J. Immunol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/CJI.0000000000000042","article-title":"Ligation of CD47 induces G1 arrest in EBV-transformed B cells through ROS generation, p38 MAPK\/JNK activation, and Tap73 upregulation","volume":"37","author":"Park","year":"2014","journal-title":"J. Immunother."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.18632\/oncotarget.7100","article-title":"A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer","volume":"7","author":"Kaur","year":"2016","journal-title":"Oncotarget"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"26069","DOI":"10.1074\/jbc.M605040200","article-title":"CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1","volume":"281","author":"Isenberg","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Xu, Y., Jiang, P., Xu, Z., and Ye, H. (2024). Opportunities and challenges for anti-CD47 antibodies in hematological malignancies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1348852"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jare.2023.10.009","article-title":"Deciphering the role of CD47 in cancer immunotherapy","volume":"63","author":"Liu","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_180","first-page":"E2842","article-title":"Inhibitory signaling through signal regulatory protein-alpha is not sufficient to explain the antitumor activities of CD47 antibodies","volume":"109","author":"Miller","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"18342","DOI":"10.1073\/pnas.1106550108","article-title":"CD47-signal regulatory protein-alpha (SIRPalpha) interactions form a barrier for antibody-mediated tumor cell destruction","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2005-04-1463","article-title":"Species- and cell type-specific interactions between CD47 and human SIRPalpha","volume":"107","author":"Subramanian","year":"2006","journal-title":"Blood"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1074\/jbc.M603923200","article-title":"Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site","volume":"282","author":"Subramanian","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature18935","article-title":"CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis","volume":"536","author":"Kojima","year":"2016","journal-title":"Nature"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1161\/ATVBAHA.107.155390","article-title":"Blocking thrombospondin-1\/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia","volume":"27","author":"Isenberg","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41574-024-01077-6","article-title":"Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors","volume":"21","author":"Iwama","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.biocel.2016.05.005","article-title":"Divergent modulation of normal and neoplastic stem cells by thrombospondin-1 and CD47 signaling","volume":"81","author":"Kaur","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/cvr\/cvx094","article-title":"Matricellular protein thrombospondin-1 in pulmonary hypertension: Multiple pathways to disease","volume":"113","author":"Rogers","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Kaur, S., Reginauld, B., Razjooyan, S., Phi, T., Singh, S.P., Meyer, T.J., Cam, M.C., and Roberts, D.D. (2024). Effects of a humanized CD47 antibody and recombinant SIRPalpha proteins on triple negative breast carcinoma stem cells. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1356421"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Messager, L., and Lamarthee, B. (2025). Giving monocytes their due: How CD47-SIRP-alpha reframes allograft rejection. Kidney Int.","DOI":"10.1016\/j.kint.2025.10.008"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"C45","DOI":"10.1152\/ajpcell.00089.2020","article-title":"Thrombospondin-1 in maladaptive aging responses: A concept whose time has come","volume":"319","author":"Isenberg","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e1584","DOI":"10.1002\/ctm2.1584","article-title":"Tolerating CD47","volume":"14","author":"Isenberg","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev.med.55.091902.104433","article-title":"The erbB family: Targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors","volume":"55","author":"Rowinsky","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1566524043360483","article-title":"Therapeutic antibodies","volume":"4","author":"Groner","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd.2018.75","article-title":"The promise and challenges of immune agonist antibody development in cancer","volume":"17","author":"Mayes","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"673","DOI":"10.4161\/cbt.10.7.12793","article-title":"Nimotuzumab with chemoradiation confers a survival advantage in treatment-naive head and neck tumors over expressing EGFR","volume":"10","author":"Basavaraj","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2014.01.897","article-title":"Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study","volume":"71","author":"Krupashankar","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaad.2015.03.040","article-title":"Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study","volume":"73","author":"Dogra","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.32604\/or.2025.071708","article-title":"CD47-Targeted Therapy in Cancer Immunotherapy: At a Crossroads of Promise and Challenge","volume":"33","author":"Guo","year":"2025","journal-title":"Oncol. Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/sj.bjc.6604943","article-title":"Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies","volume":"100","author":"Rolff","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/molecules14031304","article-title":"Gene knockdowns in adult animals: PPMOs and vivo-morpholinos","volume":"14","author":"Moulton","year":"2009","journal-title":"Molecules"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cpnc.21","article-title":"Using Morpholinos to Control Gene Expression","volume":"68","author":"Moulton","year":"2017","journal-title":"Curr. Protoc. Nucleic Acid. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.1401984","article-title":"Polymorphism in the innate immune receptor SIRPalpha controls CD47 binding and autoimmunity in the nonobese diabetic mouse","volume":"193","author":"Wong","year":"2014","journal-title":"J. Immunol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"pgad243","DOI":"10.1093\/pnasnexus\/pgad243","article-title":"Titrating CD47 by mismatch CRISPR-interference reveals incomplete repression can eliminate IgG-opsonized tumors but limits induction of antitumor IgG","volume":"2","author":"Hayes","year":"2023","journal-title":"Pnas Nexus"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/10409238.2015.1014024","article-title":"CD47 signaling pathways controlling cellular differentiation and responses to stress","volume":"50","author":"Kaur","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/1\/71\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:31:15Z","timestamp":1767202275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/1\/71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":205,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["cells15010071"],"URL":"https:\/\/doi.org\/10.3390\/cells15010071","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}